DNA Sequencing Market Regional Analysis

North America currently holds the highest market revenue share at 50.70%. Adoption of DNA sequencing technology is high in this region, with many major players, such as Thermo Fisher Scientific, Inc., Oxford Nanopore Technologies plc, Illumina, Inc., and Agilent Technologies Inc., present in this region. Along with this, the US companies are taking several strategic measures to continue growing their market share in the nation along with that of regional development. For instance, Complete Genomics, Inc., an American company was awarded "Oscars of Innovation" ultra-high throughput gene sequencer, DNBSEQ-T20×2* by R&D World Magazine in August 2023. Innovative product awards and recognitions of this type can be expected to spur new product innovations in the local market. 

However, the European DNA sequencing market size is expected to develop at a notable CAGR over the projection period because of rising R&D expenditures and ongoing scientific research that has enhanced the demand for cutting-edge NGS technologies. The UK DNA sequencing market is expected to grow at the highest CAGR during the forecast period due to increased development of companion diagnostics and later molecular diagnostic development facilities by major market players. Further, continued strategic partnerships between players in the European and Eastern markets are expected to drive the expansion of the market in the region during the forecast period. Several government initiatives to promote NGS technologies adoption in the France have been promoting the industry.